CITY-OF-TAMPERE
12.5.2022 07:31:08 CEST | Business Wire | Press release
Tampere’s target is ambitious, but understandable, considering the premium event facilities, unparalleled traditions, and a devoted city community helping Finland’s Home of Hockey in its bold aspirations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220511005532/en/
- This is everyone’s effort. This is the moment the whole city community has been waiting for. If there were Oscars for the event cities, our performance at 2022 IIHF Ice Hockey World Championship would win by a mile. And a half, says Perttu Pesä, the Director of Major Events at City of Tampere.
Hockey hype in Tampere is at all-time high with local teams Tappara and Ilves winning gold and bronze medals in Finnish league.
Furthermore, the games have taken place at brand-new Nokia Arena, Europe’s leading entertainment venue.
- Tampere has been a true hockey heaven throughout the spring, Atmosphere at Nokia Arena has been amazing, and we will take it to the next level together with our international friends from all over the world, says Anna-Kaisa Ikonen, Mayor of Tampere.
Tampere’s persistent work with major events, sustainability, equality, and smart city development will be the cornerstones of a successful tournament.
City offers free public transport for the game ticket holders and has provided close to 7000 tickets to specified groups, such as senior citizens and school children. Free-of-charge activity zone in the city center is open for all ages and welcomes families to try different sports activities.
Additionally, the unique smart event security solutions enable visitors to enjoy a smooth event experience during their stay.
On ice, Team Finland has a serious chance of writing history in its home tournament. After winning Olympic gold in Beijing, conquering the World Championship would make Finland the first nation to complete the double on home ice.
Links:
Free public transport : https://www.nysse.fi/en/events/ice-hockey-world-championship-2022.html
Finnish Hockey Hall of Fame: https://2022jaakiekonmmkisat.tampere.fi/en/news/renewed-hockey-hall-of-fame-finland-opened-on-april-1-2022/
Smart event security: https://2022jaakiekonmmkisat.tampere.fi/en/news/tampere-sets-the-bar-in-smart-event-security-at-ice-hockey-world-championship/
Tickets for specified groups: https://2022jaakiekonmmkisat.tampere.fi/en/news/tampere-builds-ice-hockey-world-championships-for-all-citizens/
View source version on businesswire.com: https://www.businesswire.com/news/home/20220511005532/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 13:00:00 CEST | Press release
Randomized controlled trial will evaluate both symptom progression and underlying biology Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom